肺部阿斯伯吉勒斯菌感染与异常成像成功地用奥马利祖马布治疗:一个病例报告
Xing He1,2, Zhenzhen Chang1, Haiying Yan1,2
1Department of Pulmonary and Critical Care Medicine, Cheng Du Qing Cheng Mt. Hospital, Chongzhou City, Chengdu, China.
Medicine
|June 16, 2023
概括
奥马利祖马布有效地治疗了对标准治疗无反应的喘患者的肺性阿斯伯吉洛症. 这为困难的肺部阿斯伯吉勒斯菌感染提供了新的治疗选择.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 过敏和免疫学 过敏和免疫学
背景情况:
- 肺性阿斯伯吉洛症带来了诊断和治疗方面的挑战,具有不同的临床和成像特征.
- 标准的治疗方法,如抗真菌药物和葡萄糖皮质类药物,可能不会给所有患者带来令人满意的结果.
- 吸入性皮质类固醇和长效β-激动剂的喘患者容易患上下呼吸道感染.
研究的目的:
- 在患有控制不良喘的患者中报告肺性阿斯珀吉洛斯病例.
- 评估奥马利祖马布在患有对常规治疗不耐药的肺阿斯伯吉洛症患者的疗效.
- 提出奥马利祖马布作为肺部阿斯伯吉勒斯菌感染的潜在替代疗法.
主要方法:
- 一名59岁的女性有喘病史,接受了吸入性皮质类固醇和长效β-激动剂.
- 通过在呼吸道样本中检测Aspergillus fumigatus,肺性阿斯伯吉洛症的诊断得到了证实.
- 患者最初接受了沃里康纳和B氨二的治疗,部分反应,然后因拒绝全身葡萄皮质类药物而转换为奥马利祖马布.
主要成果:
- 初始的抗真菌治疗导致了肺脱症的部分消失,但持续的病变.
- 奥马利祖马布治疗在1个月内缓解了临床症状.
- 经过1年的奥马利祖马布治疗,肺部成像显示病变完全清除,营养状况和呼吸道功能得到改善.
结论:
- 奥马利祖马布在肺部阿斯伯吉洛症病例中显示出显著的临床和成像改善.
- 这一案例表明,奥马利祖马布是肺部阿斯伯吉勒斯菌感染的可行治疗选择,该感染对一线治疗无反应.
- 需要进一步的研究来确定奥马利祖马布在治疗肺部阿斯伯吉洛症中的作用.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
357
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
357
01:27Pneumothorax-II
218
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
218
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Asthma: Pathogenesis and Management
461
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
461
01:26COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255